StockData
Xenetic Biosciences, Inc. logo

Xenetic Biosciences, Inc. (XBIO) stock

XBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 12/3064% below fair value
$1.53−0.08 (-4.97%)

Close on Nov 18, 2026Market cap $3.59MP/E –Yield –

Xenetic Biosciences operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Xenetic Biosciences's operating income for the twelve months ending Jun 30, 2026 was -$2.64M. For fiscal 2025 it was -$2.83M. The highest annual figure on record is -$2.83M in fiscal 2025.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$2.83M–
FY2024Dec 31, 2024-$4.20M–
FY2023Dec 31, 2023-$4.52M–
FY2022Dec 31, 2022-$6.72M–
FY2021Dec 31, 2021-$5.75M–
FY2020Dec 31, 2020-$13.94M–
FY2019Dec 31, 2019-$12.89M–
FY2018Dec 31, 2018-$7.28M–
FY2017Dec 31, 2017-$3.57M–
FY2016Dec 31, 2016-$47.43M–
FY2015Dec 31, 2015-$9.82M–
FY2014Dec 31, 2014-$12.92M–
FY2013Dec 31, 2013-$8.61M–
FY2012Dec 31, 2012-$6.34M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$971.69K–
Q1 FY2026Mar 31, 2026-$502.12K–
Q4 FY2025Dec 31, 2025-$623.03K–
Q3 FY2025Sep 30, 2025-$544.73K–
Q2 FY2025Jun 30, 2025-$724.41K–
Q1 FY2025Mar 31, 2025-$942.41K–
Q4 FY2024Dec 31, 2024-$1.10M–
Q3 FY2024Sep 30, 2024-$499.47K–
Q2 FY2024Jun 30, 2024-$1.34M–
Q1 FY2024Mar 31, 2024-$1.27M–
Q4 FY2023Dec 31, 2023-$1.26M–
Q3 FY2023Sep 30, 2023-$1.15M–
Q2 FY2023Jun 30, 2023-$1.20M–
Q1 FY2023Mar 31, 2023-$915.18K–
Q2 FY2022Jun 30, 2022-$2.69M–
Q1 FY2022Mar 31, 2022-$1.62M–
Q4 FY2021Dec 31, 2021-$1.87M–
Q3 FY2021Sep 30, 2021-$1.38M–
Q2 FY2021Jun 30, 2021-$1.13M–
Q1 FY2021Mar 31, 2021-$1.37M–
Q4 FY2020Dec 31, 2020-$1.22M–
Q3 FY2020Sep 30, 2020-$10.50M–
Q2 FY2020Jun 30, 2020-$982.46K–
Q1 FY2020Mar 31, 2020-$1.23M–
Q4 FY2019Dec 31, 2019-$1.23M–
Q3 FY2019Sep 30, 2019-$8.95M–
Q2 FY2019Jun 30, 2019-$1.38M–
Q1 FY2019Mar 31, 2019-$1.33M–
Q4 FY2018Dec 31, 2018-$1.64M-137.0%
Q3 FY2018Sep 30, 2018-$1.81M–
Q2 FY2018Jun 30, 2018-$1.99M–
Q1 FY2018Mar 31, 2018-$1.83M–
Q4 FY2017Dec 31, 2017$4.43M–
Q3 FY2017Sep 30, 2017-$2.24M–
Q2 FY2017Jun 30, 2017-$2.90M–
Q1 FY2017Mar 31, 2017-$2.86M–
Q4 FY2016Dec 31, 2016-$64.43K–
Q3 FY2016Sep 30, 2016-$2.25M–
Q2 FY2016Jun 30, 2016-$43.26M–

More Xenetic Biosciences figures

See a number that looks wrong?